Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8113.59
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 10-Nov-2025
NAV [Rs.]
: 169.0086
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.23 | 0.04 | 2.33 | 6.34 | 0.47 | 22.44 | 19.69 | 18.3 |
| Category Avg | -0.3 | 0.79 | 1.49 | 6.23 | 0.09 | 22.26 | 18.16 | 15.74 |
| Category Best | 1.02 | 3.03 | 3.5 | 11.24 | 9.01 | 27.3 | 21.17 | 31.53 |
| Category Worst | -1.2 | -0.66 | -1.5 | 2.91 | -9.54 | 18.62 | 14.01 | -4.18 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
21-Feb-20241000
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Max Healthcare8,91,340
Out
InName Of The CompanyNo Of Shares
Torrent Pharma.3,03,364
Zydus Lifesci.1,94,016
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.67 | 6256349 | 1,057.76 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 8.07 | 1000031 | 673.82 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.26 | 3083991 | 605.54 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.29 | 3495054 | 524.71 |
| Equity | Apollo Hospitals | Healthcare Services | 5.97 | 648795 | 498.33 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.62 | 3916074 | 468.98 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.42 | 2886684 | 285.39 |
| Equity | Medplus Health | Retailing | 3.32 | 3627277 | 276.70 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.05 | 1320549 | 254.72 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.87 | 913226 | 239.13 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.83 | 959323 | 236.50 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.81 | 2555745 | 234.66 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.59 | 1548692 | 216.39 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.39 | 68677 | 199.12 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.32 | 1702630 | 193.91 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.29 | 609112 | 190.98 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.16 | 757496 | 180.58 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.14 | 323678 | 178.23 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.10 | 4719374 | 175.60 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.01 | 999649 | 168.17 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.99 | 318249 | 165.77 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.95 | 923911 | 162.36 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.50 | 984838 | 125.19 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.48 | 3896349 | 123.88 |
| Equity | Fortis Health. | Healthcare Services | 1.35 | 1103889 | 112.93 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.32 | 230272 | 110.08 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.24 | 213659 | 103.46 |
| Equity | Max Healthcare | Healthcare Services | 1.23 | 891340 | 102.30 |
| Equity | Syngene Intl. | Healthcare Services | 1.00 | 1280492 | 83.24 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.90 | 1058503 | 75.16 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.84 | 1515264 | 69.81 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.74 | 470272 | 62.02 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.72 | 62568 | 59.78 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.61 | 1834924 | 51.22 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.43 | 492727 | 35.78 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.19 | 111738 | 16.13 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,63,683.95
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
